- Novo Nordisk says offer for Metsera adheres to restrictions under Pfizer deal Reuters
- Novo Nordisk makes offer for obesity-focused Metsera, aiming to outbid Pfizer statnews.com
- Obesity feeding frenzy risks queasy outcome TradingView
- Metsera’s Acquisition Raises Market Buzz StocksToTrade
- Novo Nordisk A/S (CPSE:NOVO B) submitted an unsolicited proposal to acquire Metsera, Inc.. MarketScreener